Free Trial
→ SpaceX eyes a 1.75 trillion valuation - here's what to know (From Brownstone Research) (Ad)tc pixel Free CNTX Stock Alerts

Context Therapeutics (CNTX) Short Interest Ratio & Short Volume

Context Therapeutics logo
$2.43 +0.13 (+5.65%)
Closing price 04:00 PM Eastern
Extended Trading
$2.43 0.00 (-0.04%)
As of 05:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Context Therapeutics Short Interest Overview

As of November 14, 2025, Context Therapeutics (CNTX) had a short interest of 690,287 shares sold short, representing 0.77% of the public float. This marks a -18.56% decrease in short interest since the prior report. The short interest ratio (days to cover) is 3.3, meaning it would take 3.3 days of the average trading volume of 1.41 million shares to cover all short positions.

Current Short Interest
690,287 shares
Previous Short Interest
847,576 shares
Change Vs. Previous Month
-18.56%
Dollar Volume Sold Short
$800.73 thousand
Short Interest Ratio
3.3 Days to Cover
Last Record Date
November 14, 2025
Outstanding Shares
91,880,000 shares
Short Percent of Float
0.77%
Today's Trading Volume
593,957 shares
Average Trading Volume
1,410,314 shares
Today's Volume Vs. Average
42%
Short Selling Context Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Context Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

CNTX Short Interest Over Time

CNTX Days to Cover Over Time

CNTX Percentage of Float Shorted Over Time

Context Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/14/2025690,287 shares $800.73 thousand -18.6%0.8%3.25 $1.16
10/31/2025847,576 shares $923.86 thousand +82.0%1.0%1.72 $1.09
10/15/2025465,800 shares $624.17 thousand -5.6%0.8%1.7 $1.34
9/30/2025493,200 shares $477.81 thousand -2.7%0.8%2.3 $0.97
9/15/2025507,000 shares $411.58 thousand -2.7%0.9%2.9 $0.81
8/31/2025521,200 shares $437.81 thousand -56.9%0.9%2.5 $0.84
8/15/20251,210,000 shares $951.42 thousand No Change2.1%4.8 $0.79
7/31/20251,210,000 shares $883.30 thousand -24.4%2.1%5.3 $0.73
7/15/20251,600,000 shares $1.18 million -4.8%2.8%7.1 $0.74
6/30/20251,680,000 shares $1.10 million -2.3%2.9%8.3 $0.66
6/15/20251,720,000 shares $1.08 million -22.9%3.0%7.1 $0.63
5/31/20252,230,000 shares $1.31 million -1.8%3.9%11 $0.59
5/15/20252,270,000 shares $1.70 million +3.2%3.9%16.6 $0.75
4/30/20252,200,000 shares $1.91 million -6.4%4.2%14.8 $0.87
4/15/20252,350,000 shares $1.98 million -2.9%4.5%14.5 $0.84
3/31/20252,420,000 shares $1.48 million +2.1%4.6%12.3 $0.61
3/15/20252,370,000 shares $1.67 million -4.1%5.4%5.6 $0.71
2/28/20252,470,000 shares $2.19 million +3.8%5.7%5.5 $0.89
2/15/20252,380,000 shares $1.96 million +4.4%5.4%5 $0.82
1/31/20252,280,000 shares $2.08 million +23.9%5.1%4.7 $0.91
1/15/20251,840,000 shares $1.80 million +20.3%4.1%3.5 $0.98
12/31/20241,530,000 shares $1.61 million +55.1%2.6%3.1 $1.05
12/15/2024986,300 shares $1.37 million +22.9%1.7%1.9 $1.39
11/30/2024802,800 shares $1.22 million -8.7%1.4%2.8 $1.52
11/15/2024879,600 shares $1.62 million -13.8%1.5%3.2 $1.84
10/31/20241,020,000 shares $2.22 million -1.0%1.7%4.1 $2.18
10/15/20241,030,000 shares $2.01 million -5.5%1.7%4.7 $1.95
9/30/20241,090,000 shares $2.14 million -35.5%1.8%6 $1.96
9/15/20241,690,000 shares $3.53 million -4.5%2.9%8 $2.09
8/31/20241,770,000 shares $4.35 million -4.8%3.0%7.7 $2.46
8/15/20241,860,000 shares $4.95 million -7.9%3.1%7.7 $2.66
7/31/20242,020,000 shares $4.36 million -1.9%3.1%7.2 $2.16
7/15/20242,060,000 shares $4.53 million -7.6%3.1%2.9 $2.20
6/30/20242,230,000 shares $4.47 million +99.1%3.4%3.2 $2.01
6/15/20241,120,000 shares $2.20 million -15.2%1.7%1.6 $1.96
5/31/20241,320,000 shares $2.61 million +30.7%2.0%2.3 $1.98
5/15/20241,010,000 shares $1.71 million +15,438.5%1.4%1.8 $1.69
4/30/20246,500 shares $8.65 thousand -83.9%0.1%0 $1.33
4/15/202440,400 shares $61.00 thousand +260.7%0.3%0.7 $1.51
3/31/202411,200 shares $15.46 thousand -34.1%0.1%0.2 $1.38
3/15/202417,000 shares $18.53 thousand +57.4%0.1%0.3 $1.09
2/29/202410,800 shares $12.31 thousand -60.0%0.1%0.2 $1.14
2/15/202427,000 shares $27.54 thousand -3.2%0.2%0.6 $1.02
1/31/202427,900 shares $28.46 thousand -14.9%0.2%0.7 $1.02
1/15/202432,800 shares $39.03 thousand +70.8%0.2%0.8 $1.19
12/31/202319,200 shares $21.70 thousand -37.9%0.1%0.4 $1.13
12/15/202330,900 shares $30.28 thousand +37.3%0.2%0.7 $0.98
11/30/202322,500 shares $19.13 thousand -37.2%0.2%0.6 $0.85
11/15/202335,800 shares $36.34 thousand -28.7%0.3%1 $1.02
10/31/202350,200 shares $53.21 thousand +11.8%0.4%1.4 $1.06
10/15/202344,900 shares $57.92 thousand +14.5%0.3%1.2 $1.29
9/30/202339,200 shares $59.19 thousand +184.1%0.3%1 $1.51
9/15/202313,800 shares $13.32 thousand +97.1%0.1%0.3 $0.97
8/31/20237,000 shares $7.21 thousand No Change0.1%0.1 $1.03
8/15/20237,000 shares $8.54 thousand -25.5%0.1%0.1 $1.22
7/31/20239,400 shares $10.34 thousand -86.9%0.1%0.1 $1.10
7/15/202371,600 shares $85.92 thousand -52.2%0.5%0.5 $1.20
6/30/2023149,900 shares $239.84 thousand +30.4%1.0%0.9 $1.60
6/15/2023115,000 shares $140.30 thousand -54.6%0.8%0.7 $1.22
5/31/2023253,300 shares $220.37 thousand +153.3%1.7%1.5 $0.87
5/15/2023100,000 shares $49.31 thousand -15.6%0.7%1 $0.49
4/30/2023118,500 shares $68.86 thousand +6.8%0.9%1 $0.58
4/15/2023111,000 shares $69.35 thousand +19.5%0.8%0.1 $0.62
3/31/202392,900 shares $52.23 thousand -54.6%0.7%0 $0.56
3/15/2023204,800 shares $141.62 thousand +33.9%1.5%0.1 $0.69
2/28/2023152,900 shares $117.73 thousand -27.2%1.1%0.1 $0.77
2/15/2023210,100 shares $175.48 thousand -53.7%1.6%0.1 $0.84
1/31/2023453,800 shares $481.03 thousand -25.1%3.3%0.2 $1.06
1/15/2023605,500 shares $443.83 thousand +676.3%4.4%0.9 $0.73
12/30/202278,000 shares $50.83 thousand -7.9%0.6%0.1 $0.65
12/15/202284,700 shares $55.90 thousand -53.2%0.6%0.6 $0.66
11/30/2022181,100 shares $249.92 thousand +11.2%1.3%0.9 $1.38
11/15/2022162,800 shares $195.36 thousand -29.6%1.2%0.8 $1.20
10/31/2022231,300 shares $291.44 thousand +616.1%1.7%0.8 $1.26
10/15/202232,300 shares $35.21 thousand -74.3%0.2%0.1 $1.09
9/30/2022125,500 shares $139.31 thousand +119.4%0.9%0.4 $1.11
9/15/202257,200 shares $92.66 thousand -58.0%0.4%0.2 $1.62
8/31/2022136,300 shares $258.97 thousand +48.6%1.0%0.4 $1.90
8/15/202291,700 shares $182.48 thousand -26.2%0.7%0.2 $1.99
7/31/2022124,200 shares $234.73 thousand -34.8%0.9%0.3 $1.89
7/15/2022190,600 shares $373.58 thousand -22.7%1.4%0.6 $1.96
6/30/2022246,700 shares $523.00 thousand -10.2%1.8%0.7 $2.12
6/15/2022274,800 shares $585.32 thousand +202.0%2.0%0.7 $2.13
5/31/202291,000 shares $203.84 thousand +104.0%0.7%0.2 $2.24
5/15/202244,600 shares $64.67 thousand +216.3%0.3%0.2 $1.45
4/30/202214,100 shares $20.45 thousand -55.1%0.1%0 $1.45
4/15/202231,400 shares $56.52 thousand -53.9%0.2%0.1 $1.80
3/31/202268,100 shares $147.78 thousand -53.4%0.5%0.2 $2.17
3/15/2022146,000 shares $261.34 thousand +129.2%1.1%0.2 $1.79
2/28/202263,700 shares $119.76 thousand -48.2%0.5%0 $1.88
2/15/2022122,900 shares $251.95 thousand +38.7%0.9%0 $2.05
1/31/202288,600 shares $180.74 thousand -11.3%0.6%0 $2.04
1/15/202299,900 shares $224.78 thousand -86.7%0.7%0 $2.25
12/31/2021749,000 shares $1.99 million No Change5.8%0.1 $2.66

CNTX Short Interest - Frequently Asked Questions

What is Context Therapeutics' current short interest?

Short interest is the volume of Context Therapeutics shares that have been sold short but have not yet been closed out or covered. As of November 14th, investors have sold 690,287 shares of CNTX short. 0.77% of Context Therapeutics' shares are currently sold short. Learn More on Context Therapeutics' current short interest.

What is a good short interest ratio for Context Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CNTX shares currently have a short interest ratio of 3.3. Learn More on Context Therapeutics's short interest ratio.

What is a good short interest percentage for Context Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.77% of Context Therapeutics' floating shares are currently sold short.

Is Context Therapeutics' short interest increasing or decreasing?

Context Therapeutics saw a drop in short interest in November. As of November 14th, there was short interest totaling 690,287 shares, a drop of 18.6% from the previous total of 847,576 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Context Therapeutics' short interest compare to its competitors?

0.77% of Context Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Context Therapeutics: Bright Minds Biosciences Inc. (11.62%), Theravance Biopharma, Inc. (11.57%), Arbutus Biopharma Corporation (11.34%), Design Therapeutics, Inc. (4.74%), Kura Oncology, Inc. (18.30%), Cullinan Therapeutics, Inc. (12.04%), ARS Pharmaceuticals, Inc. (40.53%), BioAge Labs, Inc. (4.97%), Tilray Brands, Inc. (8.86%), Alto Neuroscience, Inc. (7.73%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($79.41 billion), Invesco QQQ ($31.14 billion), iShares Russell 2000 ETF ($20.32 billion), iShares 20+ Year Treasury Bond ETF ($12.61 billion), AppLovin Corporation ($9.14 billion), Palo Alto Networks, Inc. ($8.94 billion), SPDR S&P Biotech ETF ($8.68 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($6.85 billion), Robinhood Markets, Inc. ($5.59 billion), and Strategy Inc ($5.49 billion). View all of the most shorted stocks.

What does it mean to sell short Context Therapeutics stock?

Short selling CNTX is an investing strategy that aims to generate trading profit from Context Therapeutics as its price is falling. CNTX shares are trading up $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Context Therapeutics?

A short squeeze for Context Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CNTX, which in turn drives the price of the stock up even further.

How often is Context Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNTX, twice per month. The most recent reporting period available is November, 14 2025.

What do CNTX's short interest metrics mean?

Understanding short interest metrics can help you assess how traders are positioning around a stock like CNTX:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Related Companies
Short Interest Tools

This page (NASDAQ:CNTX) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel